244 related articles for article (PubMed ID: 1374026)
21. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
Moser TL; Enghild JJ; Pizzo SV; Stack MS
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
[TBL] [Abstract][Full Text] [Related]
22. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
Behrendt N; Ploug M; Patthy L; Houen G; Blasi F; Danø K
J Biol Chem; 1991 Apr; 266(12):7842-7. PubMed ID: 1850423
[TBL] [Abstract][Full Text] [Related]
23. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
Ploug M; Rønne E; Behrendt N; Jensen AL; Blasi F; Danø K
J Biol Chem; 1991 Jan; 266(3):1926-33. PubMed ID: 1846368
[TBL] [Abstract][Full Text] [Related]
24. Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell.
Ueshima S; Matsumoto H; Izaki S; Mitsui Y; Fukao H; Okada K; Matsuo O
Cell Struct Funct; 1999 Apr; 24(2):71-8. PubMed ID: 10362070
[TBL] [Abstract][Full Text] [Related]
25. Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.
Glass WF; Kreisberg JI; Troyer DA
Am J Physiol; 1993 Mar; 264(3 Pt 2):F532-9. PubMed ID: 8384415
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
[TBL] [Abstract][Full Text] [Related]
27. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
28. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
29. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
[TBL] [Abstract][Full Text] [Related]
30. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
31. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
33. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
Hansen SH; Behrendt N; Danø K; Kristensen P
Exp Cell Res; 1990 Apr; 187(2):255-62. PubMed ID: 2156717
[TBL] [Abstract][Full Text] [Related]
34. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor.
Masucci MT; Pedersen N; Blasi F
J Biol Chem; 1991 May; 266(14):8655-8. PubMed ID: 1851152
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
37. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
Min HY; Semnani R; Mizukami IF; Watt K; Todd RF; Liu DY
J Immunol; 1992 Jun; 148(11):3636-42. PubMed ID: 1316922
[TBL] [Abstract][Full Text] [Related]
38. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
39. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.
Fibbi G; Barletta E; Dini G; Del Rosso A; Pucci M; Cerletti M; Del Rosso M
Lab Invest; 2001 Jan; 81(1):27-39. PubMed ID: 11204271
[TBL] [Abstract][Full Text] [Related]
40. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
Roldan AL; Cubellis MV; Masucci MT; Behrendt N; Lund LR; Danø K; Appella E; Blasi F
EMBO J; 1990 Feb; 9(2):467-74. PubMed ID: 1689240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]